PKC-δ binds to E-cadherin and mediates EGF-induced cell scattering

Experimental Cell Research

Volumn 315, Issue 17, 2009, Pages 2899-2913

  Singh, Raghvendra ^a   Lei, Pedro ^a   Andreadis, Stelios T ^a,b  

^a State University of New York   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Adherens junctions; Cell scattering; E cadherin; EGFR; Metastasis; Occludin; Tight junctions

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; OCCLUDIN; PROTEIN KINASE C DELTA; SMALL INTERFERING RNA; UVOMORULIN;

ARTICLE; CELL ADHESION; CELL TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INTERNALIZATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; TIGHT JUNCTION;

EID: 70349448435     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.07.002     Document Type: Article

References (58)

1. Mendelsohn J., and Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene 19 (2000) 6550-6565
2. Nicholson R.I., Gee J.M., and Harper M.E. EGFR and cancer prognosis. Eur. J. Cancer 37 Suppl. 4 (2001) S9-15
3. Tateishi M., Ishida T., Kohdono S., Hamatake M., Fukuyama Y., and Sugimachi K. Prognostic influence of the co-expression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma. Surg. Oncol. 3 (1994) 109-113
4. Rodeck U., Herlyn M., Herlyn D., Molthoff C., Atkinson B., Varello M., Steplewski Z., and Koprowski H. Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects. Cancer Res. 47 (1987) 3692-3696
5. Lu Z., Jiang G., Blume-Jensen P., and Hunter T. Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol. Cell. Biol. 21 (2001) 4016-4031
6. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., Harris P.L., Haserlat S.M., Supko J.G., Haluska F.G., Louis D.N., Christiani D.C., Settleman J., and Haber D.A. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 350 (2004) 2129-2139
7. Sordella R., Bell D.W., Haber D.A., and Settleman J. Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 305 (2004) 1163-1167
8. Di Fiore P.P., Pierce J.H., Fleming T.P., Hazan R., Ullrich A., King C.R., Schlessinger J., and Aaronson S.A. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 51 (1987) 1063-1070
9. Ekstrand A.J., James C.D., Cavenee W.K., Seliger B., Pettersson R.F., and Collins V.P. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 51 (1991) 2164-2172
10. Franovic A., Gunaratnam L., Smith K., Robert I., Patten D., and Lee S. Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 13092-13097
11. Sieg D.J., Hauck C.R., Ilic D., Klingbeil C.K., Schaefer E., Damsky C.H., and Schlaepfer D.D. FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell. Biol. 2 (2000) 249-256
12. Driver G.A., and Veale R.B. Modulation of integrin-linked kinase (ILK) expression in human oesophageal squamous cell carcinoma cell lines by the EGF and TGFbeta1 growth factors. Cancer Cell. Int. 6 (2006) 12
13. Lu Z., Ghosh S., Wang Z., and Hunter T. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell. 4 (2003) 499-515
14. Van Itallie C.M., Balda M.S., and Anderson J.M. Epidermal growth factor induces tyrosine phosphorylation and reorganization of the tight junction protein ZO-1 in A431 cells. J. Cell. Sci. 108 Pt. 4 (1995) 1735-1742
15. Singh A.B., and Harris R.C. Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells. J. Biol. Chem. 279 (2004) 3543-3552
16. Drees F., Pokutta S., Yamada S., Nelson W.J., and Weis W.I. Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell 123 (2005) 903-915
17. Yamada S., Pokutta S., Drees F., Weis W.I., and Nelson W.J. Deconstructing the cadherin-catenin-actin complex. Cell 123 (2005) 889-901
18. Yamada S., and Nelson W.J. Synapses: sites of cell recognition, adhesion, and functional specification. Annu. Rev. Biochem. 76 (2007) 267-294
19. Niessen C.M. Tight junctions/adherens junctions: basic structure and function. J. Invest. Dermatol. 127 (2007) 2525-2532
20. Muller S.L., Portwich M., Schmidt A., Utepbergenov D.I., Huber O., Blasig I.E., and Krause G. The tight junction protein occludin and the adherens junction protein alpha-catenin share a common interaction mechanism with ZO-1. J. Biol. Chem. 280 (2005) 3747-3756
21. Tunggal J.A., Helfrich I., Schmitz A., Schwarz H., Gunzel D., Fromm M., Kemler R., Krieg T., and Niessen C.M. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. Embo J. 24 (2005) 1146-1156
22. Thiery J.P., and Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell. Biol. 7 (2006) 131-142
23. Murray N.R., Baumgardner G.P., Burns D.J., and Fields A.P. Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. Evidence that beta II protein kinase C is required for proliferation. J. Biol. Chem. 268 (1993) 15847-15853
24. Datta R., Kojima H., Yoshida K., and Kufe D. Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J. Biol. Chem. 272 (1997) 20317-20320
25. Yoshida K., Wang H.G., Miki Y., and Kufe D. Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9. Embo J. 22 (2003) 1431-1441
26. Perletti G.P., Marras E., Concari P., Piccinini F., and Tashjian A.H. PKCdelta acts as a growth and tumor suppressor in rat colonic epithelial cells. Oncogene 18 (1999) 1251-1256
27. DeVries T.A., Neville M.C., and Reyland M.E. Nuclear import of PKCdelta is required for apoptosis: identification of a novel nuclear import sequence. Embo. J. 21 (2002) 6050-6060
28. Sun X., Wu F., Datta R., Kharbanda S., and Kufe D. Interaction between protein kinase C delta and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J. Biol. Chem. 275 (2000) 7470-7473
29. Konishi H., Yamauchi E., Taniguchi H., Yamamoto T., Matsuzaki H., Takemura Y., Ohmae K., Kikkawa U., and Nishizuka Y. Phosphorylation sites of protein kinase C delta in H2O2-treated cells and its activation by tyrosine kinase in vitro. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6587-6592
30. Denning M.F., Wang Y., Nickoloff B.J., and Wrone-Smith T. Protein kinase Cdelta is activated by caspase-dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinocytes. J. Biol. Chem. 273 (1998) 29995-30002
31. Konishi H., Tanaka M., Takemura Y., Matsuzaki H., Ono Y., Kikkawa U., and Nishizuka Y. Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 11233-11237
32. Green H., Rheinwald J.G., and Sun T.T. Properties of an epithelial cell type in culture: the epidermal keratinocyte and its dependence on products of the fibroblast. Prog. Clin. Biol. Res. 17 (1977) 493-500
33. Geer D.J., Swartz D.D., and Andreadis S.T. Fibrin promotes migration in a three-dimensional in vitro model of wound regeneration. Tissue Eng. 8 (2002) 787-798
34. Geer D.J., Swartz D.D., and Andreadis S.T. Biomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo. Am. J. Pathol. 167 (2005) 1575-1586
35. Singh R., and Andreadis S.T. EGF receptor activation decreases retroviral gene transfer through protein kinase C-delta. Mol. Ther. 15 (2007) 369-377
36. Jacobelli J., Chmura S.A., Buxton D.B., Davis M.M., and Krummel M.F. A single class II myosin modulates T cell motility and stopping, but not synapse formation. Nat. Immunol. 5 (2004) 531-538
37. Joseloff E., Cataisson C., Aamodt H., Ocheni H., Blumberg P., Kraker A.J., and Yuspa S.H. Src family kinases phosphorylate protein kinase C delta on tyrosine residues and modify the neoplastic phenotype of skin keratinocytes. J. Biol. Chem. 277 (2002) 12318-12323 (Electronic publication 12002 Jan 12325)
38. Rybin V.O., Guo J., Sabri A., Elouardighi H., Schaefer E., and Steinberg S.F. Stimulus-specific differences in protein kinase C delta localization and activation mechanisms in cardiomyocytes. J. Biol. Chem. 279 (2004) 19350-19361 (Electronic publication 12004 Feb 19317)
39. Royal I., and Park M. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J. Biol. Chem. 270 (1995) 27780-27787
40. Isfort R.J., Cody D.B., Stuard S.B., Randall C.J., Miller C., Ridder G.M., Doersen C.J., Richards W.G., Yoder B.K., Wilkinson J.E., and Woychik R.P. The combination of epidermal growth factor and transforming growth factor-beta induces novel phenotypic changes in mouse liver stem cell lines. J. Cell. Sci. 110 Pt 24 (1997) 3117-3129
41. Alford D., Baeckstrom D., Geyp M., Pitha P., and Taylor-Papadimitriou J. Integrin-matrix interactions affect the form of the structures developing from human mammary epithelial cells in collagen or fibrin gels. J. Cell. Sci. 111 (1998) 521-532
42. Dong G., Lee T.L., Yeh N.T., Geoghegan J., Van Waes C., and Chen Z. Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor. Oncogene 23 (2004) 6199-6208
43. Grotegut S., von Schweinitz D., Christofori G., and Lehembre F. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. Embo. J. 25 (2006) 3534-3545
44. Kraus M.H., Popescu N.C., Amsbaugh S.C., and King C.R. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. Embo. J. 6 (1987) 605-610
45. Rusch V., Baselga J., Cordon-Cardo C., Orazem J., Zaman M., Hoda S., McIntosh J., Kurie J., and Dmitrovsky E. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res. 53 (1993) 2379-2385
46. Moasser M.M., Basso A., Averbuch S.D., and Rosen N. The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells. Cancer Res. 61 (2001) 7184-7188
47. Clark A.S., West K.A., Blumberg P.M., and Dennis P.A. Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCdelta promotes cellular survival and chemotherapeutic resistance. Cancer Res. 63 (2003) 780-786
48. Regala R.P., Weems C., Jamieson L., Khoor A., Edell E.S., Lohse C.M., and Fields A.P. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Res. 65 (2005) 8905-8911
49. Cohen E.E., Lingen M.W., Zhu B., Zhu H., Straza M.W., Pierce C., Martin L.E., and Rosner M.R. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cancer Res. 66 (2006) 6296-6303
50. Tan M., Li P., Sun M., Yin G., and Yu D. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors. Oncogene 25 (2006) 3286-3295
51. Yang Z., Rayala S., Nguyen D., Vadlamudi R.K., Chen S., and Kumar R. Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchyme transition, modulates snail's subcellular localization and functions. Cancer Res. 65 (2005) 3179-3184
52. Denning M.F., Dlugosz A.A., Howett M.K., and Yuspa S.H. Expression of an oncogenic rasHa gene in murine keratinocytes induces tyrosine phosphorylation and reduced activity of protein kinase C delta. J. Biol. Chem. 268 (1993) 26079-26081
53. Denning M.F., Dlugosz A.A., Threadgill D.W., Magnuson T., and Yuspa S.H. Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta. J. Biol. Chem. 271 (1996) 5325-5331
54. Murugappan S., Shankar H., Bhamidipati S., Dorsam R.T., Jin J., and Kunapuli S.P. Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKCdelta in platelets. Blood 106 (2005) 550-557
55. Ozdamar B., Bose R., Barrios-Rodiles M., Wang H.R., Zhang Y., and Wrana J.L. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307 (2005) 1603-1609
56. Martin T.A., Watkins G., Mansel R.E., and Jiang W.G. Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur. J. Cancer 40 (2004) 2717-2725
57. Kominsky S.L., Argani P., Korz D., Evron E., Raman V., Garrett E., Rein A., Sauter G., Kallioniemi O.P., and Sukumar S. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22 (2003) 2021-2033
58. Paugh B.S., Paugh S.W., Bryan L., Kapitonov D., Wilczynska K.M., Gopalan S.M., Rokita H., Milstien S., Spiegel S., and Kordula T. EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKC{delta}, and sphingosine kinase 1 in glioblastoma cells. Faseb J. 22 (2008) 455-465